We invite you to the 31st European Congress of Clinical Microbiology & Infectious Diseases (ECCMID), which will take place in Vienna, Austria and virtually from 9 – 12 July 2021. This is the first time the event will take place in summer. ECCMID, the world’s premier Clinical Microbiology & Infectious Diseases event, brings together experts […]

Welcome to the 6th Microbiome Movement - Drug Development Summit, the most comprehensive forum for microbiome drug developers, the Microbiome Movement! Continuing to unite the most forward thinking and industry researchers from the biopharmaceutical industry, our unrivaled program will uncover microbiome functionality and mechanisms, advance clinical development, overcome the key CMC challenges, whilst also discovering […]

From new infectious pathogens like SARS-CoV-2, to antimicrobial resistance and the role of microbes in climate change, to agriculture and food microbiology, and synthetic and applied microbiology – international experts will gather for World Microbe Forum to examine, discuss and envision solutions that science can offer to solve some of the gravest concerns confronting us […]

Delivering our 2021 Virtual Network Conference in an innovative online format will provide a unique opportunity to hear about the latest bacterial vaccinology research from leading international researchers in a safe environment. Talks will be delivered by a host of internationally renowned speakers from a range of disciplines, all actively involved in the research area […]

FDA, NIAID and CDC are announcing a public workshop regarding the development considerations of antimicrobial drugs for the treatment of gonorrhea. The workshop will focus on the current state and nonclinical and clinical trial design considerations regarding antimicrobial drug development for gonorrhea and include the following topic areas: Animal models Clinical pharmacology considerations Trial design […]

Infectious diseases are one of the largest threats to global public health. The focus on the threat has never been greater, with the COVID-19 pandemic demonstrating the critical need for a more proactive approach within governments, biopharma, and investment communities to overcome the pressing issues in anti-infective drug development to combat antimicrobial resistance. With some […]

CARB-X participants include Erin Duffy, Chief of R&D. Johnson & Johnson Innovation – JLABS is collaborating with the Biomedical Advanced Research and Development Authority (BARDA), a component of the Administration for Strategic Preparedness and Response in the U.S. Department of Health and Human Services, to form Blue Knight. This collaboration aims to stimulate innovation and incubation […]

How can efforts to implement Antimicrobial Resistance National Action Plans still progress despite the COVID-19 pandemic? There is no doubt COVID-19 currently represents the most obvious and urgent issue for global health security and the world is rightfully focused on tackling this pandemic. However, the challenges posed by COVID-19 are only a foretaste of what […]

In December 2019 SARS-CoV-2 the cause of COVID-19, was responsible for thousands of deaths in Wuhan, China. By March 11, 2020, WHO declared COVID-19 as a worldwide pandemic.The single most effective way to tackle this pandemic is a working vaccine, which is why Vaccine Congress West Coast is bringing together experts who have been working […]

AMR in the Light of COVID-19 - A Webinar Series Each of us is now living in a world with a nearly untreatable virus - but COVID-19 is not the only threat that we are facing. Many bacterial and fungal infections that were previously considered treatable are no longer responding to the drugs designed to […]